Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kaneko, S
Right arrow Articles by Yamaguchi, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneko, S
Right arrow Articles by Yamaguchi, N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology, Vol 29, Issue 2 96-105, Copyright © 1999 by Foundation for Promotion of Cancer Research


ORIGINAL ARTICLE

Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996

S Kaneko and N Yamaguchi
Cancer Information and Epidemiology Division, National Cancer Center Research Institute, Tokyo, Japan.

BACKGROUND: Multiple primary cancer (MPC) has been recognized as a problem commonly encountered in routine medical practice. A study of MPC is necessary not only to provide insights into the etiology of cancer, but also to provide information for effective medical care by clinical oncologists. METHODS: A cohort of 49,751 cancer patients who were admitted to the National Cancer Center Hospital between 1962 and 1996 was used to study the site relationship of MPC. Logistic and Poisson regression analyses using an internal reference group within the cohort were applied for the calculation of the prevalence odds ratio (POR) for site relationships of synchronous MPC and the incidence rate ratio (IRR) for those of metachronous MPC. RESULTS: Three site combinations with elevated risks for both synchronous and metachronous MPCs, eight with elevated risk for synchronous MPC, five with elevated risk for metachronous MPC and six with decreased risk for synchronous MPC were identified with statistical significance. Among them, the increased risk of metachronous stomach cancer following lymphoma and myeoloma (POR = 1.0 and 1.1, P > 0.05; IRR = 2.5, P < 0.05) and the inverse site-correlation of synchronous MPC between [trachea, bronchus and lung] and other sites of the upper aerodigestive tract [lip, oral cavity and pharynx] (POR = 0.5 and 0.3, P < 0.05) and esophagus (POR = 0.7 and 0.3, P < 0.05) have not been reported previously. CONCLUSIONS: Our results suggest that interventions for lymphoma and myeloma might affect the development of subsequent stomach cancer and additional etiological factors other than tobacco smoking are associated with the development of cancer in the upper aerodigestive tract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
S. Kondo, U. Yamaguchi, S. Sakurai, Y. Ikezawa, H. Chuman, U. Tateishi, K. Furuta, and T. Hasegawa
Cytogenetic Confirmation of a Gastrointestinal Stromal Tumor and Ewing Sarcoma/Primitive Neuroectodermal Tumor in a Single Patient
Jpn. J. Clin. Oncol., December 1, 2005; 35(12): 753 - 756.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. S.J. Duchateau and M. P.M. Stokkel
Second Primary Tumors Involving Non-small Cell Lung Cancer: Prevalence and Its Influence on Survival
Chest, April 1, 2005; 127(4): 1152 - 1158.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. R.M. van der Sijp, J. P.A.M. van Meerbeeck, A. P.W.M. Maat, P. E. Zondervan, H. F.B.M. Sleddens, A. N. van Geel, A. M.M. Eggermont, and W. N.M. Dinjens
Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical Importance
J. Clin. Oncol., February 15, 2002; 20(4): 1105 - 1114.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.